Value proposition

Amplifying rare & unknown metabolites/molecules in natural microbiomes for, AI datasets, for drug & ag discovery starts

Selectively Screen Biosortia’s Novel Small Molecules
Biosortia is continually expanding the novel library of small molecules (SMs) directly from natural microbiomes. Novel SMs from naturally occurring microbes in microbiomes are biologically preoptimized as the best sources of life science starting points. Activities of these small molecules are grouped in well plates according to machine learning for artificial intelligence prioritization or sorted & organized by initial screening activity potential.

Out License Data for Artificial Intelligence & Analytics
Biosortia out licenses its exclusive database on natural microbiomes to assist organizations applying machine learning & artificial intelligence for obtaining solutions, prioritization, modeling, projections, & other opportunities. Data includes environmental, habitat, species, metagenomic, genomic, metabolic pathways, gene cluster, known and novel small molecules (SMs), activities based on screening & computational analysis of (SMs). Biosortia is providing much-needed missing datasets for discovery.

Purchase Small Molecules from our Rare Known Library
Biosortia makes available rare small molecules (SMs) made from microorganisms (bacteria, fungi, archaea, & viruses) in natural microbiomes. We specialize in the ‘hard to obtain’ or large quantities by special request for rare SMs. Please provide details about your needs. Our datasets should be able to determine the producing species. Our SM library may also have isomers or natural derivatives available.

Research and Academic Collaborations
Biosortia’s scientifically validated technology platforms & systems distinctly capture never-before accessed natural microbiomes’ critical data & novel small molecules. Biosortia’s full-scale microbiome harvesting & mining platform are positioned to disrupt & transform knowledge. Consider Biosortia and our world-renowned Ph.D.s & partners for grant participation, & commercialization.
Duns #832707629 / Cage # 5TA50

microbiome, Immunology, Anti-Inflammation, Immuno-Oncology, Natural Products, cytokine, immuno-modulation, microbiome recovery, microbiome mining, microbiome chemistry, small molecule, new technology, breakthrough technology, biotech, pharma, Neuro, CNS, agrochemical, pharmaceutical, and Microbiomics